Influences on viral replication and sensitivity to GLS4, a HAP compound, of naturally occurring T109/V124 mutations in hepatitis B virus core protein
Jianghua Wang(Huazhong Agricultural University), Lai Wei(Tongji University), Qingyun Ren(National Medical Products Administration), Jing Li(Army Medical University), Yingjun Zhang(HEC Pharm (China)), Haiying Zhang(Second Affiliated Hospital of Harbin Medical University), Ran Fei(Peking University), Siegfried Goldmann, Xueyan Wang(Hunan Normal University), Dong Jiang(Chinese Academy of Sciences)
Cited by 9
Related Papers
Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids
|Science|2003|506
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
New progress in the pharmacology of protocatechuic acid: A compound ingested in daily foods and herbs frequently and heavily
|Pharmacological Research|2020|301
Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)
|Journal of Clinical and Translational Hepatology|2017|277
Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
|Journal of Experimental & Clinical Cancer Research|2015|271